HemaSphere
(Jan 2022)
S113: COST OF ILLNESS, EPIDEMIOLOGY AND HEALTHCARE RESOURCE UTILIZATION FOR SICKLE CELL DISEASE IN GULF COUNTRIES (CESCGU)
- S Alkindi,
- J Altooq,
- H Dewedar,
- D Soliman,
- S Elsawy,
- A Ibrahim
Affiliations
- S Alkindi
- 1 Sultan Qaboos University, Muscat, OMAN
- J Altooq
- 2 Salmaniyah Medical Complex, Manama, BAHRAIN
- H Dewedar
- 3 Dubai Health Authority, Dubai, UNITED ARAB EMIRATES
- D Soliman
- 4 Novartis, Dubai, UNITED ARAB EMIRATES
- S Elsawy
- 5 Accsight, Cairo, EGYPT
- A Ibrahim
- 6 Accsight, Dubai, UNITED ARAB EMIRATES
- DOI
-
https://doi.org/10.1097/01.HS9.0000821420.25455.37
- Journal volume & issue
-
Vol. 6
pp.
7
– 7
WeChat QR code